Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort study.
Kim MJ, Jung J, Ji W, Choi CM, Kim SJ, Cho HJ, Hwang YG, Kim EY, Lee SY, Yoo SS, Choi S, Oh IJ, Kim YC, Park CK, Yoon SH, Kim YS, Kim MH, Lee MK, Eom JS, Kim SH, Lee JE, Chung C, Yeo CD, Lee SH, Lee JC.
Kim MJ, et al. Among authors: yeo cd.
Transl Lung Cancer Res. 2026 Jan 31;15(1):13. doi: 10.21037/tlcr-2025-aw-1216. Epub 2026 Jan 26.
Transl Lung Cancer Res. 2026.
PMID: 41659259
Free PMC article.